Humacyte’s Bioengineered Tissue Platform Technology

Humacyte’s Bioengineered Tissue Platform Technology

MPO's Sean Fenske speaks with Dr. Juliana Blum of Humacyte about the company’s regenerative medicine product.

By Sean Fenske, Editor-in-Chief03.08.22
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Juliana Blum, Co-founder and Executive Vice President of Corporate Development at Humacyte. She speaks to the technology behind their regenerative solution and how it can be leveraged as a technology platform to fulfill a variety of bioengineered tissue needs. Specifically, the following questions are addressed.

  • What is Humacyte and tell us a bit about your technology?
  • What are the applications for bioengineered tissue?
  • Obviously without giving away trade secrets, can you tell us a bit about how it is fabricated?
  • What were the major challenges that needed to be overcome to develop this?
  • What’s ahead for Humacyte?

Listen to this episode and see what you think of the company’s bioengineered tissue technology platform. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.